Vaxcyte's total assets for Q3 2025 were $3.17B, a decrease of -4.05% from the previous quarter. DE:5VA total liabilities were $278.72M for the fiscal quarter, a 19.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.